文献速递烧伤创面修复

氨甲环酸减少急性烧伤手术中的输血需求:一项回顾性病例对照试验

Tranexamic acid reduced blood transfusions in acute burn surgery: A retrospective case-controlled trial.
PubMed 文献 · Burns · 2022-03-16

研究纳入2018年1月至2021年5月烧伤ICU患者,将首次削痂植皮术前接受氨甲环酸的26例与未接受者按1:2匹配52例对照,比较输血需求。氨甲环酸组术中及总红细胞输注量显著更少,血浆和血小板等血制品各时段及总量亦更少,住院时长和死亡率无显著差异。作者认为围术期氨甲环酸可能显著减少急性烧伤手术输血需求,需随机对照试验证实。

要点

  • 氨甲环酸组术中红细胞输注量2.5单位(IQR 2.0)显著少于对照组4.0单位(IQR 4.0),p=0.038。
  • 氨甲环酸组总红细胞输注量4.0单位(IQR 3.0)显著少于对照组6.0单位(IQR 4.0),p=0.017。
  • 两组住院时长与死亡率无显著差异(死亡率15.4% vs 21.2%,p=0.542)。

核心结论

  • 围术期给予氨甲环酸可能显著减少急性烧伤手术的输血需求,但需随机对照试验证实。

研究设计与样本

  • 回顾性病例对照试验,将2018年1月至2021年5月烧伤ICU收治、首次削痂植皮术前接受氨甲环酸的26例患者,按年龄、性别、烧伤总面积以1:2匹配52例未接受氨甲环酸的对照。

主要发现

  • 氨甲环酸组术中红细胞输注量2.5单位(IQR 2.0)vs 对照组4.0单位(IQR 4.0),p=0.038。
  • 氨甲环酸组总红细胞输注量4.0单位(IQR 3.0)vs 对照组6.0单位(IQR 4.0),p=0.017。
  • 氨甲环酸组各时段及总血制品(红细胞、新鲜冰冻血浆、血小板)输注量均少于对照组。
  • 住院时长24.0天(IQR 26.0)vs 33.0天(IQR 0.5),p=0.367;死亡率15.4% vs 21.2%,p=0.542,均无显著差异。

关键数值与推荐

  • 主要终点为术中及术后48小时内红细胞总输注单位数,同时评估新鲜冰冻血浆和血小板。
  • 组间比较采用van Elteren检验,按年龄、性别、烧伤总面积分层校正。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需随机对照试验证实这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Early excision and grafting of burn wounds are key for reducing prevalence of infection and sepsis. However, it is associated with massive blood loss and patients frequently require large numbers of blood transfusions. This study aimed to evaluate the effect of tranexamic acid (TXA) on blood transfusion requirements in acute burn surgery. METHODS: Patients admitted to the burn intensive care unit between January 2018 and May 2021 and received TXA before first surgery for wound excision and grafting were matched in a 1:2 ratio to patients that did not receive TXA (confounders age,sex,total body surface area (TBSA) burned). Primary endpoint of the analysis was the total number of transfused units of red blood cells (RBC) intra- and postoperatively up to 48 h. Fresh frozen plasma (FFP) and platelets were evaluated. Endpoints were compared between groups using van Elteren tests adjusting for strata variable age, gender, TBSA. RESULTS: Twenty-six TXA patients were matched with 52 control patients resulting in similar distributions of gender (77.9%(TXA)vs. 82.7%(control) males, p=0.542), age (51.7±21.3vs.48.3 ±17.4years,p = 0.459) and %TBSA burned (33.5%(IQR34)vs. 38.5% (IQR 30.5),p = 1.000). TXA group received significantly less RBC units intraoperatively (2.5(IQR 2.0)vs.4.0 units (IQR4.0), p = 0.038) and in total (4.0(IQR3.0)vs.6.0(IQR4.0),p = 0.017). TXA patients also received less blood products in general (RBC, FFP, platelets) in each period and in total. We found no significant difference in length of stay (24.0(IQR26.0)vs.33.0 days (IQR 0.5),p = 0.367) or mortality (15.4%vs.21.2%, p = 0.542). DISCUSSION: This study shows that necessity for blood transfusions in acute burn surgery may be reduced significantly by administration of TXA perioperatively. Randomized-controlled trials are needed to prove these findings.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Tapking C, Hundeshagen G, Kirchner M, et al. Tranexamic acid reduced blood transfusions in acute burn surgery: A retrospective case-controlled trial. Burns. 2022. PMID: 35339324. doi:10.1016/j.burns.2022.03.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。